Naringgenin, ginsenoside Rb1, and Leonurus japonicus Houtt extract, which recruit insulin receptor substrate-1 (IRS-1), activate PI3K/Akt to induce protein kinase A (PKA) and serum and glucocorticoid kinase 3 (SGK-3β), ultimately promote glycogen and lipolysis synthesis, and inhibit hyperinsulinemia and NAFLD [149]. The gene discussed is IRS1; the disease is Hyperinsulinemia.